Seeking Alpha
24 Sept 2026, 05:32 UTC · 1h ago
Verdict
Source says Upgrade. We score NUTX +1.00 across two claims.
Score confirms the headline.
Upgrade
Rating stated in the headline
+1.00strongly bullish
What the story claims
2 claims · scored −1 bearish … +1 bullish · 0 new · 2 priced in
Consensus EPS projections for FY2026 and FY2027 have materially increased, with FY2026 EPS now expected at $27.79.
Priced inanalysis of consensus projections
So whatThe shift to a 10.5x forward PE suggests a valuation gap compared to typical healthcare growth multiples.
More positive than 93% of claims this week
Nutex Health's target price has been raised to $290.43, implying a 39.1% upside.
Continue reading
5 related stories
More positive than 98% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Priced inrating upgrade analysis
So whatA target price of $290.43 shifts the expected valuation floor for the next 12 months.
More positive than 77% of claims this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The company received a Strong Buy rating with significant target price upside and positive profitability metrics.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
6h ago
—
NUTX hasn't traded since this ran. Last close $201.86 (Sep 23); the reaction starts at the next open.
NUTX chart →
